Pulmonary Disease Clinical Trial
Official title:
Influence of Early Standing Training on ICU Patients
Influence of early standing training on ICU patients
Status | Not yet recruiting |
Enrollment | 50 |
Est. completion date | October 1, 2021 |
Est. primary completion date | October 1, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 100 Years |
Eligibility |
Inclusion Criteria: - The age is = 18 years old; - the hemodynamics is stable; - 50 < heart rate < 120 beats / min ; - 90 < systolic blood pressure < 200mmHg ; - 55 < mean arterial pressure < 120mmHg; - do not increase the dose of pressor drugs for at least 2 hours; - intracranial pressure is stable and there are no seizures within 24 hours; - the respiratory state is stable; - the patient's finger pulse oxygen saturation = 88%; - Oxygen concentration less than 60%; - Terminal positive expiratory pressure<12cmH2O; - 10 < respiratory frequency < 35 beats / min. Exclusion Criteria: - Pregnancy; - acute cardio-cerebrovascular events; - spinal or limb fractures; - active bleeding. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Chinese PLA General Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Medical Research Council | Muscle strength assessment of ICU patients,Out of 60 points,Less than 48 points had acquired muscle weakness in the ICU. | day 1 | |
Primary | Medical Research Council | Muscle strength assessment of ICU patients,Out of 60 points,Less than 48 points had acquired muscle weakness in the ICU. | day 7 | |
Primary | Medical Research Council | Muscle strength assessment of ICU patients,Out of 60 points,Less than 48 points had acquired muscle weakness in the ICU. | day 14 | |
Primary | Berg Balance Scale | Balance grade score,The highest 56 points,The higher the score, the better the balance. | day 1 | |
Primary | Berg Balance Scale | Balance grade score,The highest 56 points,The higher the score, the better the balance. | day 7 | |
Primary | Berg Balance Scale | Balance grade score,The highest 56 points,The higher the score, the better the balance. | day 14 | |
Primary | FIM Function Independent Scale | Functional independence assessment,The lowest score is 18 and the highest is 126,The higher the score, the more independent it is. | day 1 | |
Primary | FIM Function Independent Scale | Functional independence assessment,The lowest score is 18 and the highest is 126,The higher the score, the more independent it is. | day 7 | |
Primary | FIM Function Independent Scale | Functional independence assessment,The lowest score is 18 and the highest is 126,The higher the score, the more independent it is. | day 14 | |
Primary | Holden walk classification | Levels 0 to 5,The higher the grade, the better the ability to walk | day 1 | |
Primary | Holden walk classification | Levels 0 to 5,The higher the grade, the better the ability to walk | day 7 | |
Primary | Holden walk classification | Levels 0 to 5,The higher the grade, the better the ability to walk | day 14 | |
Primary | arterial blood gas analysis | PH,normal range 7.35-7.45 | day 1 | |
Primary | arterial blood gas analysis | PH,normal range 7.35-7.45 | day 7 | |
Primary | arterial blood gas analysis | PH,normal range 7.35-7.45 | day 14 | |
Primary | partial pressure of carbon dioxide | normal range 35-45 mmHg | day 1 | |
Primary | partial pressure of carbon dioxide | normal range 35-45 mmHg | day 7 | |
Primary | partial pressure of carbon dioxide | normal range 35-45 mmHg | day 14 | |
Primary | oxygenation index | Normal adults are 400,the higher,the better | day 1 | |
Primary | oxygenation index | Normal adults are 400,the higher,the better | day 7 | |
Primary | oxygenation index | Normal adults are 400,the higher,the better | day 14 | |
Primary | lactic acid | normal range 0.5-1.6mmol/L | day 1 | |
Primary | lactic acid | normal range 0.5-1.6mmol/L | day 7 | |
Primary | lactic acid | normal range 0.5-1.6mmol/L | day 14 | |
Primary | Diaphragmatic movement | The distance the diaphragm moves downward during inhalation,Normal adults are 1.4cm. | day 1 | |
Primary | Diaphragmatic movement | The distance the diaphragm moves downward during inhalation,Normal adults are 1.4cm. | day 7 | |
Primary | Diaphragmatic movement | The distance the diaphragm moves downward during inhalation,Normal adults are 1.4cm. | day 14 | |
Primary | Diaphragm contraction rate | Normal adults are 1.3cm/s | day 1 | |
Primary | Diaphragm contraction rate | Normal adults are 1.3cm/s | day 7 | |
Primary | Diaphragm contraction rate | Normal adults are 1.3cm/s | day 14 | |
Primary | Diaphragm thickness at end of breath | Normal adults are 0.15cm | day 1 | |
Primary | Diaphragm thickness at end of breath | Normal adults are 0.15cm | day 7 | |
Primary | Diaphragm thickness at end of breath | Normal adults are 0.15cm | day 14 | |
Primary | Diaphragm thickness at end of inhalation | Normal adults are 0.28cm | day 1 | |
Primary | Diaphragm thickness at end of inhalation | Normal adults are 0.28cm | day 7 | |
Primary | Diaphragm thickness at end of inhalation | Normal adults are 0.28cm | day 14 | |
Primary | Diaphragmatic thickness variation rate | Less than 20% have diaphragmatic dysfunction | day 1 | |
Primary | Diaphragmatic thickness variation rate | Less than 20% have diaphragmatic dysfunction | day 7 | |
Primary | Diaphragmatic thickness variation rate | Less than 20% have diaphragmatic dysfunction | day 14 | |
Primary | E-T index | Product of inspiratory time and diaphragmatic mobility,The higher the extubation success rate, the higher the extubation success rate. | day 1 | |
Primary | E-T index | Product of inspiratory time and diaphragmatic mobility,The higher the extubation success rate, the higher the extubation success rate. | day 7 | |
Primary | E-T index | Product of inspiratory time and diaphragmatic mobility,The higher the extubation success rate, the higher the extubation success rate. | day 14 | |
Primary | Timed Inspiration | Normal adults are 1s | day 1 | |
Primary | Timed Inspiration | Normal adults are 1s | day 7 | |
Primary | Timed Inspiration | Normal adults are 1s | day 14 | |
Primary | Rectus femoris thickness | The thicker the muscle, the better | day 1 | |
Primary | Rectus femoris thickness | The thicker the muscle, the better | day 7 | |
Primary | Rectus femoris thickness | The thicker the muscle, the better | day 14 | |
Primary | Thickness of tibialis anterior muscle | The thicker the muscle, the better | day 1 | |
Primary | Thickness of tibialis anterior muscle | The thicker the muscle, the better | day 7 | |
Primary | Thickness of tibialis anterior muscle | The thicker the muscle, the better | day 14 | |
Secondary | Mechanical ventilation time | Mechanical ventilation time | three months | |
Secondary | icu length of stay | icu length of stay | three months | |
Secondary | Time required for independent walking | Time required for independent walking | three months | |
Secondary | delirium | Confusion Assessment Method of the Intensive Care Unit. Positive is delirium. | 28 days | |
Secondary | mortality | mortality | 28 days | |
Secondary | reintubation | Note whether intubation was performed within 28 days. | 28 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03572335 -
Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)
|
||
Recruiting |
NCT06088485 -
The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
|
||
Terminated |
NCT03309358 -
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
|
Phase 1 | |
Active, not recruiting |
NCT02504697 -
DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer
|
||
Completed |
NCT01443845 -
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
|
Phase 4 | |
Terminated |
NCT00524095 -
Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis
|
Phase 2 | |
Completed |
NCT00210249 -
Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment
|
||
Completed |
NCT00023114 -
p450 Mediated Lung Toxicity
|
N/A | |
Recruiting |
NCT06056882 -
Simultaneous CLE Guided Crybiopsy in Patients With Pulmonary Nodules
|
||
Completed |
NCT03994848 -
Incentive Spirometry Prehabilitation Study
|
N/A | |
Completed |
NCT00366509 -
Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
|
||
Withdrawn |
NCT05100160 -
Gabapentin for the Reduction of Opiate Use Following Pulmonary Resection (GROUP Trial)
|
Phase 3 | |
Completed |
NCT03229473 -
Fall Risk Assessment in COPD
|
||
Recruiting |
NCT04767074 -
A Non-pharmacological Cough Control Therapy
|
N/A | |
Not yet recruiting |
NCT03899298 -
Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions
|
Phase 1 | |
Completed |
NCT04996693 -
On Dose Efficiency of Modern CT-scanners in Chest Scans
|
N/A | |
Recruiting |
NCT04996173 -
Cryospray Therapy Versus Standard of Care for Benign Airway Stenosis (CryoStasis)
|
N/A | |
Completed |
NCT04601545 -
The Virtual Reality Therapy as a Pulmonary Rehabilitation Supporting Method
|
N/A | |
Recruiting |
NCT03937583 -
Screening for Cancer in Patients With Unprovoked VTE
|
Phase 4 | |
Recruiting |
NCT02862418 -
Imaging of Lungs With a New Type of Magnetic Resonance Imaging (MRI) Called UTE (Ultrashort Echo Time)
|